7108 Phase II study of IMC-1121B in patients with metastatic renal cell carcinoma (mRCC) following failure of VEGFR-2 tyrosine kinase inhibitor (TKI) therapy: interim results (IMCL CP12–0605/NCT00515697)

Saved in:
Bibliographic Details
Published in:European journal of cancer supplements 2009, Vol.7 (2), p.425-425
Main Authors: Garcia, J.A, Hudes, G, Choueiri, T.K, Stadler, W.M, Wood, L, Bhatia, S, Youssoufian, H, Rowinsky, E.K, Schwartz, J.D, Thompson, J.A
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1359-6349
1878-1217
DOI:10.1016/S1359-6349(09)71441-7